NCT03378947View on ClinicalTrials.gov

EBV-associated Diffuse Large B Cell Lymphoma

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

January 15, 2018

Study Completion Date

November 1, 2018

Conditions
To Characterize and Compare Clinical, Pathological and Molecular Features
Interventions
OTHER

clinical and pathological data EBV-related GZL and DLBCL

"Invesrigators will retrospectively collect clinical and pathological data of all EBV-related GZL and DLBCL in immunocompetent patients diagnosed in the pathology department Centre Hospitalier Lyon Sud.~Investigators will analyze their clinical feature and prognosis."

Trial Locations (1)

69310

HCL, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03378947 - EBV-associated Diffuse Large B Cell Lymphoma | Biotech Hunter | Biotech Hunter